Pediatrix Medical Group, Inc. - 10-Q Summary
Business Context and Reporting Period
This Form 10-Q covers the quarterly period ended March 31, 1998. Pediatrix Medical Group, Inc. operates as a provider of pediatric medical services. The reporting period reflects significant expansion through the acquisition of eight physician group practices, with two additional acquisitions completed subsequent to the quarter-end.
Key Financial Metrics
| Metric | Q1 1998 | Q1 1997 |
|---|---|---|
| Net Patient Service Revenue | $37,808,000 | $27,013,000 |
| Net Income | $6,119,000 | $4,308,000 |
| Net Income Margin | 16.2% | 15.9% |
| Diluted EPS | $0.39 | $0.28 |
| Operating Cash Flow | $6,685,000 | $3,296,000 |
| Cash and Equivalents (End of Period) | $2,947,000 | $22,311,000 |
| Working Capital | $12,601,000 | $53,908,000 (Dec 31, 1997) |
| Total Debt (Notes Payable) | $2,700,000 | $2,750,000 (Dec 31, 1997) |
Material Changes vs. Prior Period
- Revenue Growth: Net patient service revenue increased 40.0% to $37.8 million, driven primarily by new units from acquisitions. Same-unit revenue grew 3.7%.
- Expense Increases: Salaries and benefits rose 33.8% ($6.0 million increase) due to new physician hires and support staff. Depreciation and amortization surged 115.6% to $1.7 million, largely due to goodwill amortization from acquisitions.
- Profitability: Income from operations increased 51.3% to $9.9 million. Net income rose 42.0% to $6.1 million.
- Liquidity Shift: Cash and cash equivalents dropped significantly from $18.6 million to $2.9 million. Working capital decreased by $41.3 million, primarily due to $49.4 million in cash used for physician group acquisitions.
- Investment Income: Decreased from $735,000 to $446,000 as funds were deployed for acquisitions rather than held in marketable securities.
Outlook, Risks, and Management Commentary
- Acquisition Strategy: The Company continues an aggressive acquisition strategy. In Q1 1998, eight practices were acquired for approximately $48.6 million in cash and stock. Two more were acquired post-quarter-end for $13.4 million in cash and stock.
- Liquidity Outlook: Management anticipates that operating cash flows, existing cash, and credit facility availability will be sufficient to meet working capital and capital expenditure needs for the next twelve months.
- Risks and Contingencies: The Company faces pending legal actions, primarily medical malpractice claims, which are generally covered by insurance. Management does not expect a material adverse effect. An IRS examination for tax years 1992-1994 concluded with no material impact.
- Accounting Changes: The Company adopted SFAS No. 130 regarding comprehensive income reporting in Q1 1998.
Investor Verification Checklist
- Verify the sustainability of the 40% revenue growth rate given the heavy reliance on acquisitions versus organic same-unit growth (3.7%).
- Monitor the rapid depletion of cash reserves ($15.6 million decrease in Q1) and the company's ability to fund future acquisitions without diluting shareholders or increasing debt significantly.
- Review the amortization schedule for the $48.6 million in goodwill and other intangibles acquired, as this will impact future operating margins.
- Confirm the status of the credit facility mentioned in the liquidity section to ensure it remains available as a backup for working capital.